TRLV cannot be traded this run due to a missing price feed, and beneath that data gap sits a mixed picture: a consistent earnings beat streak and strong Piotroski quality offset by margin-compression value-trap signals and declining revenue.
Thesis pillars
- Value Trap Margin Compression↑Improving
- Strong Piotroski Cash Quality→Stable
- Declining Revenue Trend→Stable
- +2 more pillars — see the Why tab for full reasoning
Trulieve Cannabis Corp. Subordi (TRLV) Stock Analysis
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. Multiple concerning factors at $11.95: Overbought (RSI 78); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7).
Trulieve Cannabis Corp. is a vertically integrated, multi-state cannabis operator headquartered in Tallahassee, Florida, describing itself as the largest cannabis retailer in the United States with market-leading positions in Arizona, Florida, Georgia, Pennsylvania, and West... Read more
Sell if holding. Multiple concerning factors at $11.95: Overbought (RSI 78); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.5/10, moderate confidence.
Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 62d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
About Trulieve Cannabis Corp. Subordi
About Trulieve Cannabis Corp. Subordi
Trulieve operates 233 dispensaries and 15 cultivation and processing facilities across nine U.S. states as of December 31, 2025, anchored by market-leading positions in Florida, Pennsylvania, and Arizona that the company organizes into three regional hubs: Southeast, Northeast, and Southwest. Florida alone accounts for 162 of the company's dispensaries and five of its 15 cultivation and processing facilities, including a 750,000-square-foot automated indoor cultivation facility.
Trulieve earns revenue by cultivating, processing, and retailing its own branded cannabis products — premium tier brands including Avenue, Cultivar Collection, and Muse alongside value-tier brands Co2lors and Roll One — supplemented by partner brands such as Alien Labs, Khalifa Kush, and Seed Junky sold through more than 200 of its retail locations. In Florida and Georgia the company is fully vertically integrated from cultivation through retail, while in Arizona, Maryland, Pennsylvania, and West Virginia it has achieved varying degrees of vertical integration to support wholesale and retail operations. In December 2025, Trulieve redeemed the full $368.0 million principal of its 8.0% Senior Secured Notes due 2026 and issued $140.0 million of new 10.5% Senior Secured Notes due 2030, followed by a $60.0 million second tranche in January 2026, refinancing its balance sheet as it also pursues a conditional Texas Dispensing Organization license awarded in December 2025.
Show full overview
Trulieve's business remains legally exposed at the federal level: cannabis is classified as a Schedule I controlled substance under the Controlled Substances Act even though, as of December 31, 2025, adult-use cannabis is legal in 24 states plus the District of Columbia, Guam, the Northern Mariana Islands, and the U.S. Virgin Islands. On December 18, 2025, President Trump signed an Executive Order directing the Attorney General to complete the rulemaking process to reschedule marijuana to Schedule III of the CSA in the most expeditious manner, a change that, if finalized, would ease the tax and banking constraints tied to Schedule I status but remains subject to completion of a formal rulemaking process with no fixed deadline.
See also: Healthcare · Drug Manufacturers - Specialty & Generic
From Trulieve Cannabis Corp. Subordi's most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-09-03Recent Developments — Trulieve Cannabis Corp. Subordi
Latest news
- NEWS TRLV|Trulieve Cannabis Subordinate Voting Ord Shs|Price:8.370|Chg%:+0.040 - TradingKey — TradingKey neutral
- NEWS TRLV|Trulieve Cannabis Subordinate Voting Ord Shs|Price:8.370|Chg%:+0.040 - tradingkey.com — tradingkey.com neutral
- NEWS Trulieve Shareholders Overwhelmingly Approve Move From British Columbia to Delaware - NewsBreak: Local News & Alerts — NewsBreak: Local News & Alerts positive
- NEWS Trulieve Shareholders Overwhelmingly Approve Move From British Columbia to Delaware - The Marijuana Herald — The Marijuana Herald positive
- NEWS Trulieve to Highlight Growth Strategy at Canaccord Genuity Conference - TipRanks — TipRanks neutral
Generated 2026-09-03T19:17:44Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-07-02Item 5.02MEDIUMTrulieve eliminated the stand-alone Chief Accounting Officer position and terminated Brett Walsh without cause, effective June 30, 2026; CFO Jan Reese was appointed principal accounting officer with no compensation adjustment.SEC filing →
- 2026-06-12Item 5.02MEDIUMPresident Jason Pernell mutually agreed to terminate his employment with Trulieve effective June 11, 2026, entering a Separation Agreement with a mutual release and a one-year equity lock-up. No successor named in the disclosed text.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $11.95: Overbought (RSI 78); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $11.19. Score 5.5/10, moderate confidence.
Take-profit target: $15.82 (+31.5% upside). Prior stop was $11.19. Stop-loss: $11.19.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7); Overbought (RSI 78).
Trulieve Cannabis Corp. Subordi trades at a P/E of N/A (forward 21.0). TrendMatrix value score: 8.2/10. Verdict: Sell.
13 analysts cover TRLV with a consensus score of 4.1/5. Average price target: $18.
What does Trulieve Cannabis Corp. Subordi do?Trulieve Cannabis Corp. is a vertically integrated, multi-state cannabis operator headquartered in Tallahassee,...
Trulieve Cannabis Corp. is a vertically integrated, multi-state cannabis operator headquartered in Tallahassee, Florida, describing itself as the largest cannabis retailer in the United States with market-leading positions in Arizona, Florida, Georgia, Pennsylvania, and West Virginia. As of December 31, 2025, the company operated 233 dispensaries and 15 cultivation and processing facilities across nine states, organized into three regional hubs, selling owned brands such as Avenue, Cultivar Collection, and Muse alongside partner brands to medical and adult-use cannabis customers.